期刊文献+

Roscovitine对增生期肝癌细胞周期的影响 被引量:1

Roscovitine on cell cycle in mitotic hepatoma carcinoma cell
原文传递
导出
摘要 目的探讨细胞周期蛋白依赖激酶抑制剂Roscovitine对增生期肝癌细胞SMMC-7721细胞周期的影响。方法采用体外培养的肝癌细胞SMMC-7721,经过Roscovitine作用后,对SMMC-7721细胞的形态、生长情况、细胞周期时相的分布、凋亡以及CDK2、Caspase-3、bcl-2mRNA的表达情况进行观察。结果MTT提示:Roscovitine对SMMC-7721细胞的增生有抑制作用,作用效果呈时间、剂量依赖性,并促进细胞的凋亡;流式细胞仪发现G0期、G1期的比例增加,细胞出现凋亡;R-T PGR显示CDK2mRNA表达水平降低,凋亡相关基因bcl-2表达降低,Caspase-3mRNA水平表达升高。结论Roscovitine可以抑制增生期肝癌细胞的生长、增生,阻滞细胞周期于G0/G1期,诱导细胞的凋亡,凋亡机制与bcl-2、Caspase-3的表达改变有关。 Objective To study the influences by a Cyclin-dependent kinase inhibitor Roscovitine on cell cycle in mitotic hepatoma carcinoma cell SMMC-7721. Methods Microscope,MTT, flow cytometry and R-T PCR were used to observe the effects of Roscovitine on morphology, proliferation, cell cycle, apoptosis and the mRNA expression of CDK2, Caspase-3, bcl-2 in SMMC-7721 cells. Results Roscovitine inhibited the proliferation of SMMC-7721 cells in dosage and time dependent manner and induced apoptosis. Flow cytometry showed the ratio of G0, G1 increased. R-T PCR showed that the expression of bcl-2 reduced, Caspase-3 increased. Conclusion Roscovitine can inhibit the growth, proliferation, block the cell cycle at G0/G1 and promotes apoptosis of mitotic SMMC-7721 cells, and the mechanism of apoptosis is dependent on the activity of bcl-2 and Caspase-3.
出处 《国际外科学杂志》 2009年第4期229-232,共4页 International Journal of Surgery
关键词 细胞周期调节蛋白依赖激酶 肝癌细胞 细胞周期 增生 凋亡 cyclin-dependent kinase hepatoma carcinoma cell cell cycle proliferation apoptosis
  • 相关文献

参考文献6

  • 1仲跻巍,李相成.细胞周期调节相关蛋白在肝脏再生中的作用[J].中华肝胆外科杂志,2007,13(7):433-436. 被引量:3
  • 2Bettayeb K, Sallam H, Ferandinl Y, et al. N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine[J]. Mol Cancer Ther, 2008, 7(9) :2713-2724.
  • 3Liu L, Schwartz B, Tsubota Y, et al. Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration [ J ]. J Immunol, 2008, 180(3) :1808-1817.
  • 4Strock CJ, Park JI, Nakakura EK, et al. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells[ J]. Cancer Res, 2006, 66(15) :7509-7515.
  • 5Kar S, Wang M, Cart BI, et al. 2-Methoxyestradiol inhibits hepato- cellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis [ J]. Cancer Chemother Pharmacol, 2005, 62(5 ) :831-840.
  • 6Cai D, Latham VM Jr, Zhang X, et al. Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells [ J ]. Cancer Res, 2006, 66 (18) :9270- 9280.

二级参考文献29

  • 1Awad MM, Gruppuso PA. Cell cycle control during liver development in the rat:evidence indicating a role for cyclin D1 posttranscriptional regulation. Cell Growth Differ, 2000, 11: 325-334.
  • 2Jaumot M, Estanyol JM, Serratosa J, et al. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Hepatology, 1999, 29:385-395.
  • 3Obaya AJ, Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci, 2002, 59 : 126-142.
  • 4Loyera P, Trembleya JH. Role of CDK/cyclin complexes in transcription and RNA splicing. Cellular Signalling, 2005, 17 : 1033-1051.
  • 5Kaldis P. The cdk-activating kinase (CAK): from yeast to mammals. Cell Mol Life Sci, 1999, 55: 284-296.
  • 6Lee MH, Yang HY. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol Life Sci, 2001, 58: 1907-1922.
  • 7Russo AA, Jeffrey PD, Patten AK, et al. Crystal structure of the p27Kipl cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature, 1996, 382: 325-331.
  • 8Russo AA, Tong L, Lee JO, et al. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature, 1998, 395 : 237-243.
  • 9Yang SQ, Lin HZ, Yin M, et al. Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. Am J Physiol, 1998, 275, 14(Pt1):G696-G704.
  • 10Weinberg RA. The retinoblastoma protein and cell cycle control. Cell, 1995, 81: 323-330.

共引文献2

同被引文献17

  • 1孙惠川.肝癌术后转移复发的治疗进展[J].癌症进展,2005,3(1):30-32. 被引量:5
  • 2Kar S, Wang M, Carr BI. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis, Cancer Chemother Pharmacol 2008; 62:831-840.
  • 3Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 2000; 59:68-74.
  • 4Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 2005; 23:9408-9421.
  • 5Obaya AJ, Sedivy JM. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 2002; 59:126-142.
  • 6Sherwood PW, Osley MA. Histone regulatory (hir) mutations suppress delta insertion alleles in Saccharomyces cerevisiae. Genetics 1991; 128:729-738.
  • 7Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009; 9:285-293.
  • 8Pinhero R, Liaw P, Yankulov K. A uniform procedure for the purification of CDK7/CycH/ MAT1, CDK8/CycC and CDK9/CycT1. Biol Preced Online 2004; 6:163-172.
  • 9Morris DP, Michelotti GA, Schwinn DA. Evidence that phosphorylation of the RNA polymerase II carboxyl-terminal repeats is similar in yeast and humans. J Biol Chem 2005; 280:31368-31377.
  • 10Tamrakar S, Kapasi AJ, Spector DH. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. J Virol 2005; 79:15477-15493.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部